In contrast, studies have found that a greater severity of airflow limitation in patients with COPD (regardless of smoking status) is related to higher expression of ACE2, which could increase the susceptibility of these patients to SARS-CoV-2 infection [53, 54]. This evidence concerns the gene ACE2 and chronic obstructive pulmonary disease.